Takeda Invests $230MM in Expanding Production Capacity at LA Manufacturing Site

Takeda today announced the expansion of its Los Angeles (LA) plasma-derived therapies (PDT) production capacity for its plasma fractionation. This represents one of Takeda’s largest single investments in manufacturing capacity expansion at the LA site which is Takeda’s largest fractionation site in terms of capacity globally. The project demonstrates the commitment to better serve patients, […]